RezzRX capsules — Class I drug recall D-1248-2014
Terminated recall by Fossil Fuel Products, LLC, reported 2014-04-30, distributed nationwide. Marketed Without an Approved NDA/ANDA: Fossil Fuel Products, is recalling RezzRX due to undeclared hydroxylthi
| Recall number | D-1248-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Fossil Fuel Products, LLC, Dallas, GA, United States |
| Recall initiated | 2013-11-18 |
| Classified | 2014-04-18 |
| Reported by FDA | 2014-04-30 |
| Terminated | 2015-05-29 |
| Distributed | Nationwide (US) |
| Quantity | 50,300 capsules |
| Reason classes | undeclared allergen, unapproved product |
| Lot numbers | 11/13, QL110408B046, QL110714A102 |
Product
RezzRX capsules, Single Blister Pack and 20 count bottle, Distributed By: Fossil Fuel Products, LLC Atlanta, GA 30309
Reason for recall
Marketed Without an Approved NDA/ANDA: Fossil Fuel Products, is recalling RezzRX due to undeclared hydroxylthiohomosildenafil and aminotadalafil.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1248-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.